Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase
2023年9月14日 - 9:05PM
ビジネスワイヤ(英語)
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to participate in
the upcoming Gilmartin Group Emerging Growth Company Showcase,
taking place virtually.
Management is scheduled to present on Thursday, September 21,
2023 from 11:30 a.m. to 11:55 a.m. ET. Interested parties may
access a live and recorded webcast of the presentation on the
“Investor Relations” section of the company’s website at
www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230914484852/en/
Investor Contact Philip Taylor Gilmartin Group
415-937-5406 Investors@senseonics.com
Senseonics (AMEX:SENS)
過去 株価チャート
から 4 2024 まで 5 2024
Senseonics (AMEX:SENS)
過去 株価チャート
から 5 2023 まで 5 2024